1. Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial
   H. Zhou et al, 2017, Br J Dermatol CrossRef
2. null
   Hiroya Yamada et al, 2017 CrossRef
3. Herbal medicines and nonalcoholic fatty liver disease
   Hong Yao et al, 2016, WJG CrossRef
4. Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction
   Merilin Al Sharif et al, 2017, Toxicology and Applied Pharmacology CrossRef
5. Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt
   Chun-Jie Gao et al, 2017, Inflammation CrossRef
6. Icariin Is A PPARα Activator Inducing Lipid Metabolic Gene Expression in Mice
   Yuan-Fu Lu et al, 2014, Molecules CrossRef
7. Increase in liver cytosolic lipases activities and VLDL-TAG secretion rate do not prevent the non-alcoholic fatty liver disease in cafeteria diet-fed rats
   Anderson Fernandes de Melo et al, 2018, Biochimie CrossRef
8. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases
   Zhe Ma et al, 2019, Biomedicine & Pharmacotherapy CrossRef
9. Oxymatrine Improves Intestinal Epithelial Barrier Function Involving NF-κB-Mediated Signaling Pathway in CCl4-Induced Cirrhotic Rats
   Jian-Bo Wen et al, 2014, PLoS ONE CrossRef
10. null
    Xiao-Hua Yu et al, 2015 CrossRef
11. High fructose consumption induces DNA methylation at PPARα and CPT1A promoter regions in the rat liver
    Koji Ohashi et al, 2015, Biochemical and Biophysical Research Communications CrossRef
12. New Role of Hispidulin in Lipid Metabolism: PPARα Activator
    Xinchi Wu et al, 2016, Lipids CrossRef
13. Oxymatrine Exerts Organ- and Tissue-Protective Effects by Regulating Inflammation, Oxidative Stress, Apoptosis, and Fibrosis: From Bench to Bedside
    Xu Lan et al, 2019, Pharmacological Research CrossRef
14. Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases
    Can Cheng et al, 2020, European Journal of Pharmacology CrossRef
15. Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis
    Hong Xu et al, 2020, Front. Pharmacol. CrossRef
16. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease
    He Zhang et al, 2020, Life Sciences CrossRef
17. Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats
    Ankita Sharma et al, 2021, Food Funct. CrossRef
18. The Effect of Induced Diabetes Mellitus on the Cerebellar Cortex of Adult Male Rat and the Possible Protective Role of Oxymatrine: A Histological, Immunohistochemical and Biochemical Study
    Amany Mohamed Shalaby et al, 2021, Ultrastructural Pathology CrossRef
19. null
    Biswanath Dinda et al, 2022 CrossRef
20. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
    Zhijia Zhou et al, 2022, Front. Endocrinol. CrossRef
21. Novel dual PPARα/γ agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects
    Bhavimani Guru et al, 2022, European Journal of Pharmacology CrossRef
22. Literature Review on the Use of Herbal Extracts in the Treatment of Non- Alcoholic Fatty Liver Disease
    Yutian Wang et al, 2022, EMIDDT CrossRef
23. A novel type lavandulyl flavonoid from Sophora flavescens as potential anti-hepatic injury agent that inhibit TLR2/NF-κB signaling pathway
    Yan Lin et al, 2023, Journal of Ethnopharmacology CrossRef
24. Oxymatrine relieves high-fructose/fat-induced obesity via reprogramming the activity of lipid metabolism-related enhancer
    Luping Ren et al, 2023, Front. Endocrinol. CrossRef
25. Study on Oxymatrine-Based Research from 2001 to 2022: A Bibliometric Analysis
    Xu Lan et al, 2024, ACS Omega CrossRef
26. null
    Tanmoy Banerjee et al, 2023 CrossRef
27. Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
    Tanmoy Banerjee et al, 2024, Planta Med CrossRef